{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:23:36Z","timestamp":1740108216674,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Comput Stat"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00180-024-01458-5","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T12:02:32Z","timestamp":1708430552000},"page":"3855-3880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bayesian sequential probability ratio test for vaccine efficacy trials"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2172-5644","authenticated-orcid":false,"given":"Erina","family":"Paul","sequence":"first","affiliation":[]},{"given":"Santosh","family":"Sutradhar","sequence":"additional","affiliation":[]},{"given":"Jonathan","family":"Hartzel","sequence":"additional","affiliation":[]},{"given":"Devan V.","family":"Mehrotra","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"issue":"5","key":"1458_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403\u2013416","journal-title":"N Engl J Med"},{"issue":"4","key":"1458_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1214\/aos\/1176325757","volume":"22","author":"JO Berger","year":"1994","unstructured":"Berger JO, Brown LD, Wolpert RL (1994) A unified conditional frequentist and Bayesian test for fixed and sequential simple hypothesis testing. Ann Stat 22(4):1787\u20131807","journal-title":"Ann Stat"},{"issue":"4","key":"1458_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/sim.4780040412","volume":"4","author":"DA Berry","year":"1985","unstructured":"Berry DA (1985) Interim analyses in clinical trials: classical vs. Bayesian approaches. Stat Med 4(4):521\u2013526","journal-title":"Stat Med"},{"issue":"6","key":"1458_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1080\/03610929808832160","volume":"27","author":"IS Chan","year":"1998","unstructured":"Chan IS, Bohidar NR (1998) Exact power and sample size for vaccine efficacy studies. Commun Stat Theory Methods 27(6):1305\u20131322","journal-title":"Commun Stat Theory Methods"},{"issue":"3","key":"1458_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1191\/1740774504cn025oa","volume":"1","author":"H Chu","year":"2004","unstructured":"Chu H, Halloran ME (2004) Bayesian estimation of vaccine efficacy. Clin Trials 1(3):306\u2013314","journal-title":"Clin Trials"},{"issue":"2\u20133","key":"1458_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0168-9002(98)00780-3","volume":"417","author":"R Cousins","year":"1998","unstructured":"Cousins R (1998) Improved central confidence intervals for the ratio of Poisson means. Nucl Instrum Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip 417(2\u20133):391\u2013399","journal-title":"Nucl Instrum Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip"},{"issue":"21","key":"1458_CR7","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1002\/(SICI)1097-0258(19961115)15:21<2379::AID-SIM457>3.0.CO;2-L","volume":"15","author":"M Ewell","year":"1996","unstructured":"Ewell M (1996) Comparing methods for calculating confidence intervals for vaccine efficacy. Stat Med 15(21):2379\u20132392","journal-title":"Stat Med"},{"issue":"7","key":"1458_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/infdis\/jiq152","volume":"203","author":"PB Gilbert","year":"2011","unstructured":"Gilbert PB, Berger JO, Stablein D, Becker S, Essex M, Hammer SM, Kim JH, DeGruttola VG (2011) Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials. J Infect Dis 203(7):969\u2013975","journal-title":"J Infect Dis"},{"issue":"3","key":"1458_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/biomet\/70.3.659","volume":"70","author":"K Gordon Lan","year":"1983","unstructured":"Gordon Lan K, DeMets DL (1983) Discrete sequential boundaries for clinical trials. Biometrika 70(3):659\u2013663","journal-title":"Biometrika"},{"issue":"1","key":"1458_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/ije\/20.1.300","volume":"20","author":"M Haber","year":"1991","unstructured":"Haber M, Longini JR IM, Halloran ME (1991) Measures of the effects of vaccination in a randomly mixing population. Int J Epidemiol 20(1):300\u2013310","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1458_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/oxfordjournals.epirev.a017990","volume":"21","author":"ME Halloran","year":"1999","unstructured":"Halloran ME, Longini IM Jr, Struchiner CJ (1999) Design and interpretation of vaccine field studies. Epidemiol Rev 21(1):73\u201388","journal-title":"Epidemiol Rev"},{"key":"1458_CR12","doi-asserted-by":"publisher","DOI":"10.1201\/9780367805326","volume-title":"Group sequential methods with applications to clinical trials","author":"C Jennison","year":"1999","unstructured":"Jennison C, Turnbull BW (1999) Group sequential methods with applications to clinical trials, 1st edn. Chapman and Hall\/CRC, London. https:\/\/doi.org\/10.1201\/9780367805326","edition":"1"},{"issue":"1","key":"1458_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0378-3758(02)00408-1","volume":"119","author":"K Krishnamoorthy","year":"2004","unstructured":"Krishnamoorthy K, Thomson J (2004) A more powerful test for comparing two Poisson means. J Stat Plan Inference 119(1):23\u201335","journal-title":"J Stat Plan Inference"},{"key":"1458_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1051\/ps\/2010018","volume":"16","author":"S Laurent","year":"2012","unstructured":"Laurent S, Legrand C (2012) A Bayesian framework for the ratio of two Poisson rates in the context of vaccine efficacy trials. ESAIM Probab Stat 16:375\u2013398","journal-title":"ESAIM Probab Stat"},{"key":"1458_CR15","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"138","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Marc GP, Moreira ED, Zerbini C et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 138:2603\u20132615","journal-title":"N Engl J Med"},{"issue":"3","key":"1458_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0167-9473(99)00100-0","volume":"34","author":"RM Price","year":"2000","unstructured":"Price RM, Bonett DG (2000) Estimating the ratio of two Poisson rates. Comput Stat Data Anal 34(3):345\u2013356","journal-title":"Comput Stat Data Anal"},{"issue":"1","key":"1458_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1745-6215-15-68","volume":"15","author":"L Richert","year":"2014","unstructured":"Richert L, Doussau A, Leli\u00e8vre J-D, Arnold V, Rieux V, Bouakane A, L\u00e9vy Y, Ch\u00eane G, Thi\u00e9baut R (2014) Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I\/II trial design. Trials 15(1):68","journal-title":"Trials"},{"issue":"23","key":"1458_CR18","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B et al (2021) Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19. N Engl J Med 384(23):2187\u20132201","journal-title":"N Engl J Med"},{"key":"1458_CR19","first-page":"43","volume":"18","author":"H Sahai","year":"1993","unstructured":"Sahai H, Khurshid A (1993) Confidence intervals for the ratio of two Poisson means. Math Sci 18:43\u201350","journal-title":"Math Sci"},{"issue":"3","key":"1458_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.vaccine.2005.07.102","volume":"24","author":"NJ Shire","year":"2006","unstructured":"Shire NJ, Welge JA, Sherman KE (2006) Efficacy of inactivated hepatitis a vaccine in HIV-infected patients: a hierarchical Bayesian meta-analysis. Vaccine 24(3):272\u2013279","journal-title":"Vaccine"},{"issue":"2","key":"1458_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1214\/aoms\/1177731118","volume":"16","author":"A Wald","year":"1945","unstructured":"Wald A (1945) Sequential tests of statistical hypotheses. Ann Math Stat 16(2):117\u2013186","journal-title":"Ann Math Stat"},{"key":"1458_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2307\/2533960","volume":"53","author":"RE Weiss","year":"1997","unstructured":"Weiss RE, Wang Y, Ibrahim JG (1997) Predictive model selection for repeated measures random effects models using Bayes factors. Biometrics 53:592\u2013602","journal-title":"Biometrics"},{"issue":"4","key":"1458_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1214\/08-AOAS193","volume":"2","author":"Y Yang","year":"2008","unstructured":"Yang Y, Gilbert P, Longini IM Jr, Halloran ME (2008) A Bayesian framework for estimating vaccine efficacy per infectious contact. Ann Appl Stat 2(4):1409","journal-title":"Ann Appl Stat"}],"container-title":["Computational Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00180-024-01458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00180-024-01458-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00180-024-01458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:23:58Z","timestamp":1732091038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00180-024-01458-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1458"],"URL":"https:\/\/doi.org\/10.1007\/s00180-024-01458-5","relation":{},"ISSN":["0943-4062","1613-9658"],"issn-type":[{"type":"print","value":"0943-4062"},{"type":"electronic","value":"1613-9658"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"27 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}